Vivactil (protriptyline) is a small molecule pharmaceutical. Protriptyline was first approved as Vivactil on 1982-01-01. It is used to treat depressive disorder and psychotic affective disorders in the USA. The pharmaceutical is active against sodium-dependent noradrenaline transporter and sodium-dependent serotonin transporter.
|Indication||depressive disorder, psychotic affective disorders|
|Drug Class||Antidepressants (dibenzo[a,d]cycloheptane derivatives)|